471 related articles for article (PubMed ID: 10493100)
1. Characterization of melanocortin receptor ligands on cloned brain melanocortin receptors and on grooming behavior in the rat.
Adan RA; Szklarczyk AW; Oosterom J; Brakkee JH; Nijenhuis WA; Schaaper WM; Meloen RH; Gispen WH
Eur J Pharmacol; 1999 Aug; 378(3):249-58. PubMed ID: 10493100
[TBL] [Abstract][Full Text] [Related]
2. Cyclic lactam alpha-melanotropin analogues of Ac-Nle4-cyclo[Asp5, D-Phe7,Lys10] alpha-melanocyte-stimulating hormone-(4-10)-NH2 with bulky aromatic amino acids at position 7 show high antagonist potency and selectivity at specific melanocortin receptors.
Hruby VJ; Lu D; Sharma SD; Castrucci AL; Kesterson RA; al-Obeidi FA; Hadley ME; Cone RD
J Med Chem; 1995 Sep; 38(18):3454-61. PubMed ID: 7658432
[TBL] [Abstract][Full Text] [Related]
3. Identification of antagonists for melanocortin MC3, MC4 and MC5 receptors.
Adan RA; Oosterom J; Ludvigsdottir G; Brakkee JH; Burbach JP; Gispen WH
Eur J Pharmacol; 1994 Nov; 269(3):331-7. PubMed ID: 7895772
[TBL] [Abstract][Full Text] [Related]
4. Investigation of the melanocyte stimulating hormones on food intake. Lack Of evidence to support a role for the melanocortin-3-receptor.
Abbott CR; Rossi M; Kim M; AlAhmed SH; Taylor GM; Ghatei MA; Smith DM; Bloom SR
Brain Res; 2000 Jun; 869(1-2):203-10. PubMed ID: 10865075
[TBL] [Abstract][Full Text] [Related]
5. Differential effects of melanocortin peptides on neural melanocortin receptors.
Adan RA; Cone RD; Burbach JP; Gispen WH
Mol Pharmacol; 1994 Dec; 46(6):1182-90. PubMed ID: 7808440
[TBL] [Abstract][Full Text] [Related]
6. Effects of melanocortin receptor ligands on thyrotropin-releasing hormone release: evidence for the differential roles of melanocortin 3 and 4 receptors.
Kim MS; Small CJ; Russell SH; Morgan DG; Abbott CR; alAhmed SH; Hay DL; Ghatei MA; Smith DM; Bloom SR
J Neuroendocrinol; 2002 Apr; 14(4):276-82. PubMed ID: 11963824
[TBL] [Abstract][Full Text] [Related]
7. Long term orexigenic effect of a novel melanocortin 4 receptor selective antagonist.
Skuladottir GV; Jonsson L; Skarphedinsson JO; Mutulis F; Muceniece R; Raine A; Mutule I; Helgason J; Prusis P; Wikberg JE; Schiöth HB
Br J Pharmacol; 1999 Jan; 126(1):27-34. PubMed ID: 10051117
[TBL] [Abstract][Full Text] [Related]
8. Asp10 in Lys-gamma2-MSH determines selective activation of the melanocortin MC3 receptor.
Oosterom J; Burbach JP; Gispen WH; Adan RA
Eur J Pharmacol; 1998 Jul; 354(1):R9-11. PubMed ID: 9726642
[TBL] [Abstract][Full Text] [Related]
9. Evidence that alpha-MSH induced grooming is not primarily mediated by any of the cloned melanocortin receptors.
Sanchez MS; Celis ME; Schiöth HB
Neuropeptides; 2000 Apr; 34(2):77-82. PubMed ID: 10985923
[TBL] [Abstract][Full Text] [Related]
10. Accelerating sensory recovery after sciatic nerve crush: non-selective versus melanocortin MC4 receptor-selective peptides.
Nijenhuis WA; Wanders N; Kruijtzer JA; Liskamp RM; Gispen WH; Adan RA
Eur J Pharmacol; 2004 Jul; 495(2-3):145-52. PubMed ID: 15249163
[TBL] [Abstract][Full Text] [Related]
11. Further pharmacological characterization of the selective melanocortin 4 receptor antagonist HS014: comparison with SHU9119.
Schiöth HB; Muceniece R; Mutulis F; Bouifrouri AA; Mutule I; Wikberg JE
Neuropeptides; 1999 Jun; 33(3):191-6. PubMed ID: 10657491
[TBL] [Abstract][Full Text] [Related]
12. Conformation of the core sequence in melanocortin peptides directs selectivity for the melanocortin MC3 and MC4 receptors.
Oosterom J; Nijenhuis WA; Schaaper WM; Slootstra J; Meloen RH; Gispen WH; Burbach JP; Adan RA
J Biol Chem; 1999 Jun; 274(24):16853-60. PubMed ID: 10358030
[TBL] [Abstract][Full Text] [Related]
13. Involvement of the melanocortin MC4 receptor in stress-related behavior in rodents.
Chaki S; Ogawa S; Toda Y; Funakoshi T; Okuyama S
Eur J Pharmacol; 2003 Aug; 474(1):95-101. PubMed ID: 12909200
[TBL] [Abstract][Full Text] [Related]
14. Characterisation of melanocortin receptor subtypes by radioligand binding analysis.
Schiöth HB; Muceniece R; Wikberg JE; Chhajlani V
Eur J Pharmacol; 1995 Feb; 288(3):311-7. PubMed ID: 7774675
[TBL] [Abstract][Full Text] [Related]
15. Structure activity studies of the melanocortin-4 receptor by in vitro mutagenesis: identification of agouti-related protein (AGRP), melanocortin agonist and synthetic peptide antagonist interaction determinants.
Haskell-Luevano C; Cone RD; Monck EK; Wan YP
Biochemistry; 2001 May; 40(20):6164-79. PubMed ID: 11352754
[TBL] [Abstract][Full Text] [Related]
16. Biological and conformational examination of stereochemical modifications using the template melanotropin peptide, Ac-Nle-c[Asp-His-Phe-Arg-Trp-Ala-Lys]-NH2, on human melanocortin receptors.
Haskell-Luevano C; Nikiforovich G; Sharma SD; Yang YK; Dickinson C; Hruby VJ; Gantz I
J Med Chem; 1997 May; 40(11):1738-48. PubMed ID: 9171884
[TBL] [Abstract][Full Text] [Related]
17. Characterisation of the melanocortin 4 receptor by radioligand binding.
Schiöth HB; Muceniece R; Wikberg JE
Pharmacol Toxicol; 1996 Sep; 79(3):161-5. PubMed ID: 8884876
[TBL] [Abstract][Full Text] [Related]
18. Selectivity of cyclic [D-Nal7] and [D-Phe7] substituted MSH analogues for the melanocortin receptor subtypes.
Schiöth HB; Müceniece R; Mutulis F; Prusis P; Lindeberg G; Sharma SD; Hruby VJ; Wikberg JE
Peptides; 1997; 18(7):1009-13. PubMed ID: 9357059
[TBL] [Abstract][Full Text] [Related]
19. Discovery of novel melanocortin4 receptor selective MSH analogues.
Schiöth HB; Mutulis F; Muceniece R; Prusis P; Wikberg JE
Br J Pharmacol; 1998 May; 124(1):75-82. PubMed ID: 9630346
[TBL] [Abstract][Full Text] [Related]
20. Binding and biological activity of C-terminally modified melanocortin peptides: a comparison between their actions at rodent MC1 and MC3 receptors.
Peng PJ; Sahm UG; Doherty RV; Kinsman RG; Moss SH; Pouton CW
Peptides; 1997; 18(7):1001-8. PubMed ID: 9357058
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
